Literature DB >> 1176200

Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors.

M Glaser, H Kirchner, R B Herberman.   

Abstract

W/Fu rats were injected subcutaneously with low numbers of cells from the Gross leukemia virus-induced lymphoma, (C58NT)D, which induced transient tumor growth and regression (regressors), or with high numbers of tumor cells resulting in progressive tumor growth (progressors). Spleen cells from regressors had a significant reactivity in the mixed leukocyte tumor cell interation (MLTI), while spleen cells from progressors were unresponsive. Similarly, the responses to the non-specific mitogens, phytohemagglutinin and concanavalin A, were suppressed in spleen-cell cultures of progressors. Passage of spleen cells from progressors over rayon adherence columns or pretreatment with an iron/magnet technique resulted in almost complete restoration of MLTI and mitogen responses. Addition of spleen cells from progressors depressed the MLTI of spleen cells from regressors and the mitogen reactivity of normal spleen cells. Serum from progressors also suppressed MLTI and mitogen reactivity. These data indicate that, in spleens of rats bearing progressively growing tumors, suppressor cells can be demonstrated which inhibit specific reactivity to tumor-associated antigens and non-specific reactivity to mitogens. The presence of suppressor cells or of inhibitory factors in the serum may contribute to the immunosuppression frequently observed in tumor-bearing hosts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176200     DOI: 10.1002/ijc.2910160305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.

Authors:  G M Taylor; W D Fergusson; R Harris
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

2.  Effect of protein deficiency on suppressor cells.

Authors:  M Khorshidi; N Mohagheghpour
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

3.  Induction of suppressor macrophages in mice by Fusarenon-X.

Authors:  E Masuda; T Takemoto; T Tatsuno; T Obara
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

4.  Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis.

Authors:  T L Roszman; R J Cross; W H Brooks; W R Markesbery
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

5.  Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.

Authors:  Q W Ye; M B Mokyr; J M Pyle; S Dray
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Tumour-bearing animals synthesize a decreased level of mRNA for the inducible 55,000 MW interleukin-2 receptor.

Authors:  V Holán; M Lipoldová
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

7.  In vitro suppression of T-cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens.

Authors:  J M Sharma
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma.

Authors:  H Kimura; T Aoki
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

9.  Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours.

Authors:  S Haskill; H Koren; S Becker; W Fowler; L Walton
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.